UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
COVID-19 and SARS-CoV-2
Sir Zumla has been ranked by several independent analyses as the U.K’s top communicable diseases expert (https://expertscape.com/ex/communicable+diseases/c/uk). He is also listed top of the UK expertise on Coronaviruses (https://expertscape.com/ex/coronavirus/c/uk) and ranked 3rd in the Global list of coronavirus experts (https://expertscape.com/ex/coronavirus). Sir Zumla also featured in the Clarivate 2019 list of the world’s most influential and highly cited authors (https://www.ucl.ac.uk/infection-immunity/news/2018/nov/professor-sir-ali-zumla-cited-global-list-influential-researchers). As soon as the first cases of COVID-19 were announced in early January 2020 from Wuhan, China, Sir Zumla, utilized his extensive experience of leading ‘One-Human-Animal-Health’ networks across Africa, Europe and the Middle East on Emerging and Re-Emerging Infectious Diseases with Epidemic potential, (https://www.studyinternational.com/news/coronavirologists-leading-world/ and https://www.pandora-id.net/partners), to ‘jump start’ several international multidisciplinary collaborative research, capacity building, training and advocacy projects on COVID-19. He convinced all partners to use their own existing resources and in-kind funding. This rapid approach to COVID-19 R&D activities, (rather than apply for COVID-19 specific grant funding which wastes valuable time and effort), was based on previous experiences with Ebola where his team highlighted the recurrent missed opportunities to conduct R&D in emergency outbreak situations. (https://pubmed.ncbi.nlm.nih.gov/26231479/). B). COVID-19 INTERNATIONAL RESEARCH COLLABORATIONS ESTABLISHED Sir Zumla rapidly established COVID-19 R&D collaborations on a range of priority clinical, epi and basic science subject areas with colleagues and friends from China, Portugal, Italy, France, Ireland, Africa and the Middle East. Sir Zumla ideated, coordinated and orchestrated research, capacity development, training, advocacy, and grant writing activities with scientists, HCWs, policy makers and community charities. In Africa and Europe he utilised his existing ONE-HUMAN-ANIMAL-HEALTH consortium network, which is closely linked with the newly formed Africa CDC and Chatham House (https://www.pandora-id.net/partners) to take forward advocacy, and training activities.
1 Researchers
 More search options
Status: Active
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by